Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | OLN | LMAT |
|---|---|---|
| Price | $16.27 | $80.99 |
| Change today | ▲ 2.33% | ▲ 2.57% |
| Market cap | $1.85B | $1.85B |
| Return, 3 months | -20.6% | -23.1% |
| Return, year to date | -19.8% | +0.6% |
| Return, 1 year | -34.9% | -6.5% |
| P/E (TTM) | -9.4 | 28.3 |
| P/B | 1.1 | 4.4 |
| P/E percentile vs own 5y | – | 2nd |
| Dividend yield | 4.92% | 1.11% |
| Revenue growth (YoY, latest qtr) | +3.7% | – |
| Net profit growth (YoY) | -196.3% | – |
| Gross margin | 7.4% | – |
| Operating margin | 0.6% | – |
| Net margin | -1.5% | – |
| Return on equity | -5.2% | – |
| Analyst target vs. price | +22.9% | +32.7% |
| Analyst buy share | 9% | 67% |
| RSI (14) | 42 | 48 |
| 30-day volatility | 33.5% | 20.4% |
| Max drawdown, 1 year | -47.8% | -32.5% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
